Hartmann Viaflo

Hartmann Viaflo is an intravenous electrolyte solution containing potassium chloride, sodium chloride, calcium chloride dihydrate, and sodium lactate. The formulation is supplied as a sterile solution for infusion, with the specific concentration of each ion not publicly disclosed. It is marketed in the European Union and requires a prescription. Viaflo is used to replenish fluid volume and correct electrolyte imbalances in clinical settings for patients.

Hartmann Viaflo is indicated for intravenous fluid and electrolyte replacement in a variety of clinical situations.

- Treatment of hypokalemia (low potassium). - Management of hyponatremia (low sodium). - Correction of calcium deficiency or hypocalcemia. - Support of patients requiring fluid resuscitation after surgery or trauma. - Use in patients with metabolic acidosis where lactate serves as a buffer.

Adverse reactions to Hartmann Viaflo are generally infrequent, but they can be categorized by frequency and severity.

Common: - Mild infusion site irritation or pain. - Transient nausea or vomiting. - Slight increase in serum chloride levels. - Temporary mild hypernatremia.

Serious: - Severe hyperkalemia leading to cardiac arrhythmia. - Rapid fluid overload causing pulmonary edema. - Allergic reaction with rash, urticaria, or anaphylaxis. - Metabolic alkalosis from excess lactate conversion.

When prescribing Hartmann Viaflo, clinicians should evaluate patient-specific factors and monitor relevant laboratory values.

- Assess baseline electrolyte concentrations, especially potassium, sodium, and calcium. - Monitor cardiac rhythm in patients at risk for arrhythmias. - Use caution in renal impairment due to reduced electrolyte excretion. - Avoid rapid infusion in patients with heart failure or pulmonary edema. - Adjust dose in patients receiving diuretics or other electrolyte-modifying drugs. - Consider pregnancy status; safety data are limited.

Hartmann Viaflo may interact with other medications that affect electrolyte balance or fluid status.

Avoid: - Concurrent use of potassium-sparing diuretics or potassium supplements, which can precipitate hyperkalemia. - High-dose sodium bicarbonate, which may exacerbate hypernatremia. - Calcium channel blockers combined with large calcium loads, increasing risk of hypercalcemia.

Use with caution: - Loop diuretics, which can cause rapid shifts in potassium and sodium. - ACE inhibitors or ARBs, which may alter potassium handling. - Insulin therapy, which drives potassium into cells and may require electrolyte monitoring.